Henry Schein, Inc. is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The technology and value-added services segment provides software, technology and other value-added services to healthcare practitioners. Its technology group offerings include practice management software systems for dental and medical practitioners and animal health clinics. The Company provides its services to dental practitioners and laboratories, animal health clinics and physician practices, as well as government and institutional healthcare clinics.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Equipment Wholesale
- Sub-Industry: Health Care Distributors
- Symbol: NASDAQ:HSIC
- CUSIP: 80640710
- Web: www.henryschein.com
Capitalization:- Market Cap: $12.58571 billion
- Outstanding Shares: 79,055,000
Average Prices:- 50 Day Moving Avg: $85.78
- 200 Day Moving Avg: $88.02
- 52 Week Range: $73.11 - $93.50
P/E:- Trailing P/E Ratio: 11.61
- Foreward P/E Ratio: 19.99
- P/E Growth: 2.19
Sales & Book Value:- Annual Revenue: $11.97 billion
- Price / Sales: 0.53
- Book Value: $36.95 per share
- Price / Book: 2.17
Profitability:- EBIDTA: $1.02 billion
- Net Margins: 4.59%
- Return on Equity: 19.91%
- Return on Assets: 8.34%
Debt:- Debt-to-Equity Ratio: 0.28%
- Current Ratio: 1.55%
- Quick Ratio: 0.85%
Misc:- Average Volume: 1.07 million shs.
- Beta: 1.1
- Short Ratio: 5.11
Frequently Asked Questions for Henry Schein (NASDAQ:HSIC)
What is Henry Schein's stock symbol?
Henry Schein trades on the NASDAQ under the ticker symbol "HSIC."
When did Henry Schein's stock split? How did Henry Schein's stock split work?
Henry Schein shares split before market open on Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly issued shares were distributed to shareholders after the market closes on Thursday, September 14th 2017. An investor that had 100 shares of Henry Schein stock prior to the split would have 200 shares after the split.
How will Henry Schein's stock buyback program work?
Henry Schein declared that its Board of Directors has authorized a stock repurchase program on Tuesday, September 19th 2017, which authorizes the company to repurchase $400,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to purchase up to 6.3% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company's management believes its stock is undervalued.
How were Henry Schein's earnings last quarter?
Henry Schein, Inc. (NASDAQ:HSIC) posted its quarterly earnings results on Tuesday, August, 8th. The company reported $0.88 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.87 by $0.01. The company earned $3.06 billion during the quarter, compared to analyst estimates of $3.05 billion. Henry Schein had a net margin of 4.59% and a return on equity of 19.91%. The firm's quarterly revenue was up 6.4% on a year-over-year basis. During the same period in the previous year, the business earned $0.82 EPS. View Henry Schein's Earnings History.
What guidance has Henry Schein issued on next quarter's earnings?
Henry Schein issued an update on its FY17 earnings guidance on Tuesday, August, 8th. The company provided EPS guidance of $7.17-7.30 for the period, compared to the Thomson Reuters consensus estimate of $7.29.
Where is Henry Schein's stock going? Where will Henry Schein's stock price be in 2017?
16 analysts have issued 12 month price targets for Henry Schein's shares. Their predictions range from $81.50 to $109.00. On average, they anticipate Henry Schein's stock price to reach $92.17 in the next year. View Analyst Ratings for Henry Schein.
Who are some of Henry Schein's key competitors?
Some companies that are related to Henry Schein include Edwards Lifesciences Corporation (EW), Incyte Corporation (INCY), C.R. Bard (BCR), Zimmer Biomet Holdings (ZBH), Cerner Corporation (CERN), Cardinal Health (CAH), Quintiles Transitional Holdings (Q), AmerisourceBergen Corporation (Holding Co) (ABC), Teva Pharmaceutical Industries Limited (TEVA), Mylan N.V. (MYL), BioMarin Pharmaceutical (BMRN), Lonza Group Ag (LZAGY), Centene Corporation (CNC), Smith & Nephew SNATS (SNN), Laboratory Corporation of America Holdings (LH), Eisai Co., Ltd (ESALY), Align Technology (ALGN) and Grifols, S.A. (GRFS).
Who are Henry Schein's key executives?
Henry Schein's management team includes the folowing people:
- Stanley M. Bergman, Chairman of the Board, Chief Executive Officer
- James P. Breslawski CPA, President, Director; Chief Executive Officer of Henry Schein Global Dental Group
- Steven Paladino CPA, Chief Financial Officer, Executive Vice President, Director
- Peter McCarthy, President of Global Animal Health Group
- David C. McKinley, President of Corporate Commercial Development Group, Chief Commercial Officer
- Bob Minowitz, President, International Dental Group, EMEA Region
- Bridget A. Ross, President of Global Medical Group
- Gerald A. Benjamin, Chief Administrative Officer, Executive Vice President, Director
- Mark E. Mlotek, Chief Strategic Officer, Executive Vice President, Director
- Karen N. Prange, Executive Vice President; Chief Executive Officer of Global Animal Health, Medical and Dental Surgical Group
Who owns Henry Schein stock?
Henry Schein's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (10.19%), FMR LLC (8.72%), BlackRock Inc. (7.18%), State Street Corp (4.56%), Alecta Pensionsforsakring Omsesidigt (3.16%) and Janus Henderson Group PLC (1.85%). Company insiders that own Henry Schein stock include Barry J Alperin, David Mckinley, Donald J Kabat, Gerald A Benjamin, James A Harding, Kurt P Kuehn, Lonnie Shoff, Lorelei Mcglynn, Louis W Sullivan, Mark E Mlotek, Michael Racioppi, Michael S Ettinger, Norman S Matthews, Paul Brons, Paul Rose, Peter M Mccarthy, Philip A Laskawy, Robert Minowitz, Stanley Komaroff, Stanley M Bergman and Steven Paladino. View Institutional Ownership Trends for Henry Schein.
Who sold Henry Schein stock? Who is selling Henry Schein stock?
Henry Schein's stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Atlanta Capital Management Co. L L C, JPMorgan Chase & Co., Findlay Park Partners LLP, Bank of New York Mellon Corp, Neuberger Berman Group LLC, State Street Corp and TIAA CREF Investment Management LLC. Company insiders that have sold Henry Schein stock in the last year include Donald J Kabat, Gerald A Benjamin, James A Harding, Lorelei Mcglynn, Mark E Mlotek, Michael Racioppi, Michael S Ettinger, Paul Rose, Philip A Laskawy and Steven Paladino. View Insider Buying and Selling for Henry Schein.
Who bought Henry Schein stock? Who is buying Henry Schein stock?
Henry Schein's stock was bought by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Vanguard Group Inc., PGGM Investments, AMI Asset Management Corp, BlackRock Inc., Martingale Asset Management L P, Balyasny Asset Management LLC and AJO LP. View Insider Buying and Selling for Henry Schein.
How do I buy Henry Schein stock?
Shares of Henry Schein can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Henry Schein's stock price today?
One share of Henry Schein stock can currently be purchased for approximately $80.35.
MarketBeat Community Rating for Henry Schein (NASDAQ HSIC)MarketBeat's community ratings are surveys of what our community members think about Henry Schein and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Henry Schein (NASDAQ:HSIC) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 10 Hold Ratings, 6 Buy Ratings |
| Consensus Rating: | Hold (Score: 2.38) |
| Consensus Price Target: | $92.17 (14.71% upside) |
Analysts' Ratings History for Henry Schein (NASDAQ:HSIC)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 9/21/2017 | Morgan Stanley | Initiated Coverage | Equal -> Equal Weight | $88.00 | Low |  |
| 9/19/2017 | Royal Bank Of Canada | Initiated Coverage | Sector Perform -> Sector Perform | $91.00 | High | |
| 9/15/2017 | Piper Jaffray Companies | Upgrade | Neutral -> Overweight | | Low | |
| 8/29/2017 | Credit Suisse Group | Reiterated Rating | Hold | $87.50 | Low | |
| 8/7/2017 | Northcoast Research | Upgrade | Neutral -> Buy | $109.00 | High | |
| 7/21/2017 | Jefferies Group LLC | Reiterated Rating | Hold | $88.50 | Low | |
| 7/6/2017 | Stifel Nicolaus | Reiterated Rating | Hold | | Low | |
| 5/10/2017 | Barrington Research | Boost Price Target | Outperform -> Outperform | $98.00 -> $99.00 | Low | |
| 4/11/2017 | Craig Hallum | Initiated Coverage | Hold | | Low | |
| 3/15/2017 | Deutsche Bank AG | Initiated Coverage | Hold -> Hold | $87.00 | Low | |
| 2/22/2017 | Leerink Swann | Set Price Target | Hold | $91.50 | N/A | |
| 2/21/2017 | Evercore ISI | Boost Price Target | Hold | $80.00 -> $89.00 | N/A | |
| 1/10/2017 | Gabelli | Upgrade | Hold -> Buy | $104.00 | N/A | |
| 1/3/2017 | Robert W. Baird | Upgrade | Neutral -> Outperform | $82.00 -> $85.00 | N/A | |
| 11/3/2016 | J P Morgan Chase & Co | Reiterated Rating | Hold | $81.50 | N/A | |
| 10/11/2016 | Goldman Sachs Group, Inc. (The) | Upgrade | Neutral -> Buy | $92.50 | N/A | |
| 9/12/2016 | Bank of America Corporation | Initiated Coverage | Buy | $92.50 | N/A | |
(Data available from 9/26/2015 forward)
Earnings History for Henry Schein (NASDAQ:HSIC)Earnings History by Quarter for Henry Schein (NASDAQ HSIC)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 8/8/2017 | Q2 17 | $0.87 | $0.88 | $3.05 billion | $3.06 billion | View | Listen | |
| 5/9/2017 | Q1 17 | $0.83 | $0.88 | $2.83 billion | $2.92 billion | View | Listen | |
| 2/21/2017 | Q416 | $0.93 | $0.94 | $3.08 billion | $3.12 billion | View | Listen | |
| 11/2/2016 | Q316 | $0.83 | $0.84 | $2.88 billion | $2.87 billion | View | N/A | |
| 8/4/2016 | Q216 | $0.82 | $0.82 | $2.85 billion | $2.87 billion | View | N/A | |
| 5/3/2016 | Q116 | $0.70 | $0.71 | $2.66 billion | $2.70 billion | View | Listen | |
| 2/10/2016 | Q415 | $0.83 | $0.84 | $2.82 billion | $2.90 billion | View | Listen | |
| 11/4/2015 | Q315 | $0.74 | $0.78 | $2.70 billion | $2.70 billion | View | Listen | |
| 7/29/2015 | Q215 | $0.73 | $0.73 | $2.68 billion | $2.60 billion | View | Listen | |
| 5/4/2015 | Q1 | $0.64 | $0.64 | $2.54 billion | $25.00 billion | View | Listen | |
| 2/11/2015 | Q414 | $0.76 | $0.78 | $2.72 billion | $2.70 billion | View | Listen | |
| 11/6/2014 | Q314 | $0.66 | $0.67 | $2.55 billion | $2.62 billion | View | Listen | |
| 8/4/2014 | Q214 | $0.67 | $0.68 | $2.56 billion | $2.60 billion | View | Listen | |
| 5/6/2014 | Q1 | $0.57 | $0.59 | $2.43 billion | $2.40 billion | View | Listen | |
| 2/11/2014 | Q413 | $0.70 | $0.72 | $2.53 billion | $2.50 billion | View | Listen | |
| 11/5/2013 | Q313 | $0.61 | $0.61 | $2.37 billion | $2.30 billion | View | Listen | |
| 8/6/2013 | Q2 2013 | $0.62 | $0.62 | $2.39 billion | $2.40 billion | View | Listen | |
| 5/7/2013 | Q1 2013 | $0.54 | $0.53 | $2.25 billion | $2.30 billion | View | Listen | |
| 2/13/2013 | Q4 2012 | $0.61 | $0.63 | $2.40 billion | $2.40 billion | View | Listen | |
| 11/7/2012 | Q312 | $0.54 | $0.54 | $2.24 billion | $2.23 billion | View | N/A | |
| 8/2/2012 | | $0.55 | $0.56 | | | View | N/A | |
| 5/8/2012 | | $0.46 | $0.49 | | | View | N/A | |
| 2/15/2012 | | $0.56 | $0.58 | | | View | N/A | |
| 11/1/2011 | | $0.50 | $0.50 | | | View | N/A | |
| 8/2/2011 | | $0.50 | $0.51 | | | View | N/A | |
| 5/3/2011 | | $0.40 | $0.41 | | | View | N/A | |
| 2/22/2011 | | $0.48 | $0.50 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Henry Schein (NASDAQ:HSIC)2017 EPS Consensus Estimate: $7.16
2018 EPS Consensus Estimate: $8.08
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 5 | $1.60 | $1.67 | $1.64 |
| Q2 2017 | 5 | $1.71 | $1.77 | $1.74 |
| Q3 2017 | 5 | $1.75 | $1.85 | $1.80 |
| Q4 2017 | 5 | $1.97 | $1.99 | $1.98 |
| Q1 2018 | 3 | $1.87 | $2.01 | $1.93 |
| Q2 2018 | 3 | $1.94 | $2.02 | $1.98 |
| Q3 2018 | 3 | $1.98 | $2.02 | $1.99 |
| Q4 2018 | 3 | $2.15 | $2.22 | $2.18 |
(Data provided by Zacks Investment Research)
Dividend History for Henry Schein (NASDAQ:HSIC)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Henry Schein (NASDAQ:HSIC)Insider Ownership Percentage: 1.27%
Institutional Ownership Percentage: 44.52%
Insider Trades by Quarter for Henry Schein (NASDAQ:HSIC)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 9/6/2017 | Paul Rose | SVP | Sell | 2,126 | $172.51 | $366,756.26 | |
| 5/11/2017 | Gerald A Benjamin | EVP | Sell | 12,578 | $175.10 | $2,202,407.80 | |
| 3/23/2017 | Lorelei Mcglynn | SVP | Sell | 9,300 | $171.76 | $1,597,368.00 | |
| 3/20/2017 | Michael Racioppi | SVP | Sell | 9,969 | $171.69 | $1,711,577.61 | |
| 3/17/2017 | Mark E Mlotek | EVP | Sell | 5,559 | $170.98 | $950,477.82 | |
| 3/8/2017 | James A Harding | SVP | Sell | 10,552 | $171.60 | $1,810,723.20 | |
| 3/8/2017 | Philip A Laskawy | Director | Sell | 1,103 | $171.51 | $189,175.53 | |
| 3/2/2017 | Michael S Ettinger | SVP | Sell | 6,960 | $171.09 | $1,190,786.40 | |
| 2/27/2017 | Donald J Kabat | Director | Sell | 4,334 | $173.62 | $752,469.08 | |
| 2/22/2017 | Paul Rose | SVP | Sell | 6,821 | $173.24 | $1,181,670.04 | |
| 2/22/2017 | Steven Paladino | CFO | Sell | 13,072 | $173.40 | $2,266,684.80 | |
| 12/12/2016 | Kurt P Kuehn | Director | Buy | 1,000 | $151.41 | $151,410.00 | |
| 11/3/2016 | Mark E Mlotek | EVP | Sell | 2,417 | $155.19 | $375,094.23 | |
| 8/29/2016 | Paul Brons | Director | Sell | 3,381 | $164.03 | $554,585.43 | |
| 6/2/2016 | Gerald A Benjamin | EVP | Sell | 9,991 | $175.08 | $1,749,224.28 | |
| 5/16/2016 | James A Harding | SVP | Sell | 10,302 | $172.60 | $1,778,125.20 | |
| 5/12/2016 | Peter M Mccarthy | Insider | Sell | 1,158 | $171.75 | $198,886.50 | |
| 3/15/2016 | Lonnie Shoff | CEO | Sell | 3,028 | $168.29 | $509,582.12 | |
| 3/14/2016 | David Mckinley | Insider | Sell | 3,339 | $167.92 | $560,684.88 | |
| 3/14/2016 | Norman S Matthews | Director | Sell | 5,335 | $167.75 | $894,946.25 | |
| 3/10/2016 | Donald J Kabat | Director | Sell | 1,218 | $168.38 | $205,086.84 | |
| 3/7/2016 | Barry J Alperin | Director | Sell | 1,635 | $167.36 | $273,633.60 | |
| 3/7/2016 | Michael S Ettinger | SVP | Sell | 5,423 | $168.13 | $911,768.99 | |
| 3/4/2016 | Philip A Laskawy | Director | Sell | 1,317 | $166.88 | $219,780.96 | |
| 3/2/2016 | Louis W Sullivan | Director | Sell | 11,735 | $168.59 | $1,978,403.65 | |
| 3/2/2016 | Mark E Mlotek | EVP | Sell | 4,982 | $167.93 | $836,627.26 | |
| 2/26/2016 | Barry J Alperin | Director | Sell | 7,540 | $167.96 | $1,266,418.40 | |
| 2/24/2016 | Robert Minowitz | Insider | Sell | 9,648 | $165.48 | $1,596,551.04 | |
| 2/22/2016 | Michael Racioppi | SVP | Sell | 21,567 | $166.74 | $3,596,081.58 | |
| 2/17/2016 | Stanley Komaroff | Insider | Sell | 8,000 | $163.53 | $1,308,240.00 | |
| 2/16/2016 | Norman S Matthews | Director | Sell | 4,230 | $160.05 | $677,011.50 | |
| 2/12/2016 | Steven Paladino | CFO | Sell | 11,727 | $157.21 | $1,843,601.67 | |
| 2/11/2016 | Donald J. Kabat | Director | Sell | 6,637 | $156.36 | $1,037,761.32 | |
| 12/17/2015 | Michael Racioppi | SVP | Sell | 9,901 | $155.92 | $1,543,763.92 | |
| 12/10/2015 | Stanley M. Bergman | CEO | Sell | 61,800 | $155.45 | $9,606,810.00 | |
| 11/9/2015 | Paul Rose | SVP | Sell | 3,638 | $151.92 | $552,684.96 | |
| 11/5/2015 | Mark E. Mlotek | EVP | Sell | 2,952 | $155.00 | $457,560.00 | |
| 11/5/2015 | Stanley Komaroff | Insider | Sell | 6,297 | $154.89 | $975,342.33 | |
| 9/16/2015 | Philip A Laskawy | Director | Sell | 4,000 | $136.20 | $544,800.00 | |
| 5/6/2015 | Paul Brons | Director | Sell | 3,801 | $136.70 | $519,596.70 | |
| 3/19/2015 | Michael S Ettinger | SVP | Sell | 4,352 | $139.75 | $608,192.00 | |
| 3/18/2015 | James P Breslawski | CEO | Sell | 12,811 | $139.45 | $1,786,493.95 | |
| 3/17/2015 | Leonard A David | SVP | Sell | 3,935 | $140.00 | $550,900.00 | |
| 3/16/2015 | Paul Rose | SVP | Sell | 3,264 | $140.13 | $457,384.32 | |
| 3/13/2015 | Norman S Matthews | Director | Sell | 9,200 | $136.07 | $1,251,844.00 | |
| 3/11/2015 | Philip A Laskawy | Director | Sell | 2,669 | $136.60 | $364,585.40 | |
| 3/10/2015 | Donald J Kabat | Director | Sell | 2,002 | $138.00 | $276,276.00 | |
| 3/5/2015 | Barry J Alperin | Director | Sell | 6,637 | $140.64 | $933,427.68 | |
| 2/24/2015 | Stanley Komaroff | Insider | Sell | 8,000 | $141.69 | $1,133,520.00 | |
| 2/12/2015 | Donald J Kabat | Director | Sell | 5,000 | $142.68 | $713,400.00 | |
| 2/12/2015 | Gerald A Benjamin | EVP | Sell | 22,116 | $142.71 | $3,156,174.36 | |
| 2/12/2015 | Robert Minowitz | Insider | Sell | 11,254 | $142.63 | $1,605,158.02 | |
| 12/18/2014 | Leonard A David | SVP | Sell | 3,557 | $135.34 | $481,404.38 | |
| 12/9/2014 | Stanley M Bergman | CEO | Sell | 69,600 | $135.56 | $9,434,976.00 | |
| 12/8/2014 | Stanley M Bergman | CEO | Sell | 23,485 | $136.34 | $3,201,944.90 | |
| 11/24/2014 | Stanley Komaroff | Insider | Sell | 13,757 | $133.06 | $1,830,506.42 | |
| 11/7/2014 | Lorelei Mcglynn | SVP | Sell | 15,746 | $129.03 | $2,031,706.38 | |
| 11/7/2014 | Mark E Mlotek | EVP | Sell | 6,262 | $128.75 | $806,232.50 | |
| 9/2/2014 | Philip A Laskawy | Director | Sell | 15,438 | $119.40 | $1,843,297.20 | |
| 8/29/2014 | Louis W Sullivan | Director | Sell | 17,262 | $119.99 | $2,071,267.38 | |
| 6/9/2014 | Barry J Alperin | Director | Sell | 7,500 | $120.39 | $902,925.00 | |
| 6/2/2014 | Gerald A Benjamin | EVP | Sell | 12,354 | $119.50 | $1,476,303.00 | |
| 5/28/2014 | Norman S Matthews | Director | Sell | 6,637 | $118.68 | $787,679.16 | |
| 5/19/2014 | Donald Kabat | Director | Sell | 5,000 | $116.30 | $581,500.00 | |
| 5/15/2014 | Paul Brons | Director | Sell | 5,363 | $113.77 | $610,148.51 | |
| 3/19/2014 | Barry Alperin | Director | Sell | 7,500 | $119.18 | $893,850.00 | |
| 3/17/2014 | Lonnie Shoff | CEO | Sell | 3,722 | $119.06 | $443,141.32 | |
| 3/12/2014 | Michael Ettinger | SVP | Sell | 3,537 | $119.20 | $421,610.40 | |
| 3/11/2014 | David Mckinley | Insider | Sell | 2,387 | $119.65 | $285,604.55 | |
| 3/11/2014 | James Breslawski | CEO | Sell | 72,642 | $119.35 | $8,669,822.70 | |
| 3/11/2014 | Paul Rose | SVP | Sell | 3,783 | $119.72 | $452,900.76 | |
| 3/10/2014 | Robert Minowitz | Insider | Sell | 11,553 | $119.98 | $1,386,128.94 | |
| 3/4/2014 | Donald Kabat | Director | Sell | 5,000 | $119.15 | $595,750.00 | |
| 2/28/2014 | Michael Racioppi | SVP | Sell | 18,614 | $118.91 | $2,213,390.74 | |
| 2/26/2014 | Stanley Komaroff | Insider | Sell | 18,000 | $119.36 | $2,148,480.00 | |
| 2/25/2014 | Mark Mlotek | EVP | Sell | 20,333 | $119.16 | $2,422,880.28 | |
| 2/20/2014 | Steven Paladino | CFO | Sell | 28,757 | $117.79 | $3,387,287.03 | |
| 2/12/2014 | Philip Laskawy | Director | Sell | 5,851 | $114.91 | $672,338.41 | |
| 12/19/2013 | Mark Mlotek | EVP | Sell | 22,004 | $111.97 | $2,463,787.88 | |
| 12/19/2013 | Michael Racioppi | SVP | Sell | 29,257 | $111.97 | $3,275,906.29 | |
| 12/17/2013 | Gerald Benjamin | EVP | Sell | 41,664 | $111.66 | $4,652,202.24 | |
| 12/17/2013 | James Breslawski | CEO | Sell | 57,754 | $111.91 | $6,463,250.14 | |
| 12/16/2013 | Steven Paladino | CFO | Sell | 47,652 | $112.31 | $5,351,796.12 | |
| 12/13/2013 | Stanley Bergman | CEO | Sell | 78,000 | $111.90 | $8,728,200.00 | |
| 12/6/2013 | Leonard David | SVP | Sell | 13,968 | $113.14 | $1,580,339.52 | |
| 11/26/2013 | Stanley Komaroff | Insider | Sell | 22,329 | $114.79 | $2,563,145.91 | |
| 8/23/2013 | Philip Laskawy | Director | Sell | 21,637 | $103.17 | $2,232,289.29 | |
| 8/22/2013 | Norman Matthews | Director | Sell | 9,851 | $103.95 | $1,024,011.45 | |
| 8/20/2013 | Louis Sullivan | Director | Sell | 15,000 | $103.91 | $1,558,650.00 | |
| 8/12/2013 | Donald Kabat | Director | Sell | 2,500 | $106.25 | $265,625.00 | |
| 6/18/2013 | Barry J Alperin | Director | Sell | 7,500 | $97.74 | $733,050.00 | |
| 5/8/2013 | James A Harding | CTO | Sell | 12,000 | $92.64 | $1,111,680.00 | |
| 3/8/2013 | Donald J Kabat | Director | Sell | 4,038 | $90.00 | $363,420.00 | |
| 12/4/2012 | Donald J Kabat | Director | Sell | 15,000 | $80.04 | $1,200,600.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Henry Schein (NASDAQ:HSIC)
Latest Headlines for Henry Schein (NASDAQ:HSIC)
| Source: |
|
| Date | Headline |
|---|
 | Henry Schein, Inc. (HSIC) Research Coverage Started at Morgan Stanley
www.americanbankingnews.com - September 21 at 10:02 AM |
 | Recent HSIC News
www.bloomberg.com - September 20 at 8:17 PM |
 | Henry Schein Joins Texas Health Care Leaders To Convene Expert-Led Symposium On Practice Recovery In Wake Of Hurricanes
finance.yahoo.com - September 20 at 8:17 PM |
 | Henry Schein (HSIC) to Increase Share Buyback Plan by $400M
www.streetinsider.com - September 20 at 5:41 AM |
| Henry Schein (HSIC) Board of Directors Announces Share Buyback Plan
www.americanbankingnews.com - September 19 at 11:04 AM |
| Henry Schein, Inc. (HSIC) Coverage Initiated by Analysts at Royal Bank Of Canada
www.americanbankingnews.com - September 19 at 7:38 AM |
 | Henry Schein To Repurchase Up To $400 Mln Of Shares
www.nasdaq.com - September 18 at 7:08 PM |
| Henry Schein Announces $400 Million Increase To Share Repurchase Plan
finance.yahoo.com - September 18 at 7:08 PM |
| Henry Schein announces share buyback of up to $400 mln
finance.yahoo.com - September 18 at 7:08 PM |
 | Looking For Amazon-Proof Stocks? Try Henry Schein - Benzinga
www.benzinga.com - September 17 at 11:45 PM |
| Henry Schein, Inc. (HSIC) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - September 16 at 4:42 AM |
| Looking For Amazon-Proof Stocks? Try Henry Schein
finance.yahoo.com - September 16 at 1:06 AM |
| Henry Schein, Inc. (HSIC) Upgraded to Overweight by Piper Jaffray Companies
www.americanbankingnews.com - September 15 at 11:40 PM |
| Henry Schein, Inc. (HSIC) Stock Rating Reaffirmed by UBS AG
www.americanbankingnews.com - September 15 at 5:34 PM |
| Thursday Sector Laggards: Services, Healthcare - Nasdaq
www.nasdaq.com - September 14 at 8:47 PM |
 | Technical Insights on Medical Equipment Wholesale Stocks -- Henry Schein, Patterson, Owens & Minor, and PharMerica - PR Newswire (press release)
www.prnewswire.com - September 14 at 8:47 PM |
| ETFs with exposure to Henry Schein, Inc. : September 14, 2017
finance.yahoo.com - September 14 at 8:47 PM |
| Market Close Report: Historical high reached as NASDAQ Composite Index closes at 6460.19. - Nasdaq
www.nasdaq.com - September 14 at 6:10 AM |
| Henry Schein, Inc. breached its 50 day moving average in a Bullish Manner : HSIC-US : September 12, 2017
finance.yahoo.com - September 12 at 11:50 PM |
| Henry Schein, Inc. (HSIC) Expected to Post Quarterly Sales of $3.05 Billion
www.americanbankingnews.com - September 12 at 6:08 AM |
 | Health-Care Stocks Poised for More Gains - Barron's
www.barrons.com - September 11 at 8:04 PM |
| Henry Schein MicroMD Software Gets ONC-Health IT Certificate
finance.yahoo.com - September 11 at 8:04 PM |
| $1.79 Earnings Per Share Expected for Henry Schein, Inc. (HSIC) This Quarter
www.americanbankingnews.com - September 10 at 10:22 AM |
| Henry Schein MicroMD EMR® Earns ONC-Health IT Certification From Drummond Group LLC
finance.yahoo.com - September 8 at 8:08 PM |
| Henry Schein, Inc. (HSIC) SVP Paul Rose Sells 2,126 Shares
www.americanbankingnews.com - September 7 at 7:42 PM |
| Henry Schein, Its Supplier Partners, And Team Schein Members To Donate $500,000 To Aid Hurricane Harvey Recovery Efforts
finance.yahoo.com - September 6 at 7:33 PM |
| Henry Schein Disaster Relief Hotline Remains Open To Support Customers Affected By Hurricane Irma
finance.yahoo.com - September 6 at 7:33 PM |
| ETFs with exposure to Henry Schein, Inc. : September 1, 2017
finance.yahoo.com - September 2 at 1:02 AM |
| Northcoast Research Weighs in on Henry Schein, Inc.'s Q4 2017 Earnings (HSIC)
www.americanbankingnews.com - September 1 at 8:36 AM |
| Henry Schein Partners With IMF And LUGPA To Raise Awareness Of The Critical Role Early Detection Plays In The Fight Against Prostate Cancer
finance.yahoo.com - August 31 at 7:35 PM |
| FY2017 EPS Estimates for Henry Schein, Inc. (HSIC) Reduced by Analyst
www.americanbankingnews.com - August 31 at 9:24 AM |
| Henry Schein's 20th Annual 'Back to School' Program Helps More Than 5,000 Kids Return to the Classroom With Confidence
finance.yahoo.com - August 31 at 5:55 AM |
| Henry Schein, Inc. (HSIC) Rating Reiterated by Credit Suisse Group
www.americanbankingnews.com - August 30 at 2:28 PM |
| Henry Schein, Inc. (HSIC) Shares to Split on Friday, September 15th
www.americanbankingnews.com - August 30 at 1:24 AM |
| Henry Schein's Merritt Buyout to Boost U.S. Veterinary Arm
www.nasdaq.com - August 29 at 8:11 PM |
| Henry Schein Supports Cancer Awareness And Research Through Its 'Practice Pink' Program
finance.yahoo.com - August 29 at 8:11 PM |
| Henry Schein, Inc. :HSIC-US: Earnings Analysis: Q2, 2017 By the Numbers : August 29, 2017
finance.yahoo.com - August 29 at 8:11 PM |
| Henry Schein (HSIC) to Acquire Merritt Veterinary Supplies - StreetInsider.com
www.streetinsider.com - August 29 at 12:14 AM |
| Henry Schein (HSIC) to Acquire Merritt Veterinary Supplies
www.streetinsider.com - August 28 at 7:13 PM |
| Earnings Review and Free Research Report: Henry Schein’s Revenue Gained 6.5%; EPS Jumped 17.1%
finance.yahoo.com - August 28 at 7:13 PM |
| Henry Schein To Acquire Merritt Veterinary Supplies
finance.yahoo.com - August 28 at 7:13 PM |
 | Henry Schein takes over Merritt Veterinary Supplies
seekingalpha.com - August 28 at 4:16 PM |
| Henry Schein Disaster Relief Hotline Is Open To Support Customers Affected By Hurricane Harvey
finance.yahoo.com - August 26 at 5:49 AM |
| Henry Schein, Inc. to Post Q3 2017 Earnings of $1.80 Per Share, Jefferies Group Forecasts (HSIC)
www.americanbankingnews.com - August 25 at 8:08 AM |
| Henry Schein, Inc. to Post Q4 2017 Earnings of $1.97 Per Share, Jefferies Group Forecasts (HSIC)
www.americanbankingnews.com - August 24 at 8:22 AM |
| Henry Schein To Present At Two Conferences In September
finance.yahoo.com - August 24 at 7:38 AM |
| Henry Schein, Inc. (HSIC) Expected to Announce Quarterly Sales of $3.05 Billion
www.americanbankingnews.com - August 24 at 1:44 AM |
| Henry Schein, Inc. (HSIC) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - August 22 at 4:28 AM |
| Cramer’s Exec Cut: The huge millennial influence on moder...
finance.yahoo.com - August 18 at 7:27 PM |
| Henry Schein (HSIC) Plans 2-for-1 Stock Split - StreetInsider.com
www.streetinsider.com - August 17 at 12:36 AM |
Henry Schein (HSIC) Chart for Tuesday, September, 26, 2017
